Skip to main content
. Author manuscript; available in PMC: 2020 Dec 29.
Published in final edited form as: World J Urol. 2018 Mar 27;36(9):1431–1440. doi: 10.1007/s00345-018-2280-0

Table 3.

Variables associated with locoregional control among pN+ patients with PeCa (n = 28)

Variables UVA MVA
HR (95% CI) p value HR (95% CI) p value
Tumor stage
 T1 Reference 0.022 Reference 0.648
 T2 3.72 (1.01–13.71) 0.048 1.29 (0.29–5.63) 0.739
 T3 1.23 (0.31–4.93) 0.774 0.84 (0.16–4.37) 0.839
 T4 53.15 (2.77–1020.21) 0.008 5.44 (0.21–142.99) 0.310
HPV/p16 status 0.24 (0.08–0.76) 0.015 0.18 (0.039–0.80) 0.024
LVI 0.36 (0.12–1.13) 0.080 0.39 (0.10–1.60) 0.192
Extent of surgery 2.55 (0.92–7.04) 0.072 1.58 (0.46–5.41) 0.463
Adjuvant CRT 0.24 (0.08–0.71) 0.010 0.19 (0.05–0.70) 0.012

Bold indicates statistical significance p values (< 0.05)

LVI Lymphovascular invasion, CRT Chemoradiotherapy, UVA Cox Univariate analysis, MVA Cox Multivariate analysis, HR Hazard ratio